Literature DB >> 16375717

Recent advances in the molecular biology of west nile virus.

David W C Beasley1.   

Abstract

Since the mid-1990s, West Nile virus (WNV) has emerged as a significant agent of arboviral encephalitis in several regions of the world. In 1999, WNV was introduced into the northeastern United States and was associated with an outbreak of encephalitis affecting humans, birds and horses. Subsequently, the virus has spread across the country, and across southern Canada, and in 2002 and 2003 was associated with the largest outbreaks of arboviral encephalitis recorded in the Western hemisphere. Interestingly, the more recent spread of WNV into Mexico, Central America and the Caribbean has not been associated with the high levels of clinical disease observed in North America. This review addresses the most recent results from studies investigating the molecular biology and evolution of WNV, as well as progress in the development of diagnostic and therapeutic reagents.

Entities:  

Mesh:

Year:  2005        PMID: 16375717     DOI: 10.2174/156652405774962272

Source DB:  PubMed          Journal:  Curr Mol Med        ISSN: 1566-5240            Impact factor:   2.222


  18 in total

1.  Switching the substrate specificity of the two-component NS2B-NS3 flavivirus proteinase by structure-based mutagenesis.

Authors:  Sergey A Shiryaev; Boris I Ratnikov; Alexander E Aleshin; Igor A Kozlov; Nicholas A Nelson; Michal Lebl; Jeffrey W Smith; Robert C Liddington; Alex Y Strongin
Journal:  J Virol       Date:  2007-02-14       Impact factor: 5.103

Review 2.  West Nile virus: A re-emerging pathogen revisited.

Authors:  Miguel A Martín-Acebes; Juan-Carlos Saiz
Journal:  World J Virol       Date:  2012-04-12

3.  Cleavage preference distinguishes the two-component NS2B-NS3 serine proteinases of Dengue and West Nile viruses.

Authors:  Sergey A Shiryaev; Igor A Kozlov; Boris I Ratnikov; Jeffrey W Smith; Michal Lebl; Alex Y Strongin
Journal:  Biochem J       Date:  2007-02-01       Impact factor: 3.857

4.  Characterization of the 8-hydroxyquinoline scaffold for inhibitors of West Nile virus serine protease.

Authors:  Manolya Ezgimen; Huiguo Lai; Niklaus H Mueller; Kyungae Lee; Gregory Cuny; David A Ostrov; Radhakrishnan Padmanabhan
Journal:  Antiviral Res       Date:  2012-02-11       Impact factor: 5.970

5.  Expression and purification of a two-component flaviviral proteinase resistant to autocleavage at the NS2B-NS3 junction region.

Authors:  Sergey A Shiryaev; Alexander E Aleshin; Boris I Ratnikov; Jeffrey W Smith; Robert C Liddington; Alex Y Strongin
Journal:  Protein Expr Purif       Date:  2006-12-01       Impact factor: 1.650

6.  High-throughput screening for the identification of small-molecule inhibitors of the flaviviral protease.

Authors:  Anuradha Balasubramanian; Mark Manzano; Tadahisa Teramoto; Rajendra Pilankatta; Radhakrishnan Padmanabhan
Journal:  Antiviral Res       Date:  2016-08-15       Impact factor: 5.970

7.  West Nile virus infection of Drosophila melanogaster induces a protective RNAi response.

Authors:  Heather L Chotkowski; Alexander T Ciota; Yongqing Jia; Francesc Puig-Basagoiti; Laura D Kramer; Pei-Yong Shi; Robert L Glaser
Journal:  Virology       Date:  2008-05-23       Impact factor: 3.616

8.  Genetic determinants of virulence in pathogenic lineage 2 West Nile virus strains.

Authors:  Elizabeth M Botha; Wanda Markotter; Mariaan Wolfaardt; Janusz T Paweska; Robert Swanepoel; Gustavio Palacios; Louis H Nel; Marietjie Venter
Journal:  Emerg Infect Dis       Date:  2008-02       Impact factor: 6.883

9.  Diversification of West Nile virus in a subtropical region.

Authors:  Daniel M Chisenhall; Christopher N Mores
Journal:  Virol J       Date:  2009-07-16       Impact factor: 4.099

10.  Lineage 2 west nile virus as cause of fatal neurologic disease in horses, South Africa.

Authors:  Marietjie Venter; Stacey Human; Dewald Zaayman; Gertruida H Gerdes; June Williams; Johan Steyl; Patricia A Leman; Janusz Tadeusz Paweska; Hildegard Setzkorn; Gavin Rous; Sue Murray; Rissa Parker; Cynthia Donnellan; Robert Swanepoel
Journal:  Emerg Infect Dis       Date:  2009-06       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.